Article
Las Vegas - Biologics, an emerging class of drugs derived from human and animal proteins, are providing effective, long-term relief to patients with moderate-to-severe psoriasis, says Mark Lebwohl, M.D., Soi and Clara Kest professor and chairman, department of dermatology, The Mount Sinai School of Medicine.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.